Life sciences executive recruitment: An employer guide

Most life sciences executive recruitment begins in a mismatched place.

A leadership role opens, someone writes a job description, and the search runs against a checklist of requirements. The order feels sensible, yet it skips an essential question: What is this person meant to do for the business?

Since 2012, our recruiters at headcount AG have placed VP and C-suite leaders across pharma, biotech, medtech and digital health in Switzerland and Europe.

As a recruiter, I have seen again and again that executive search is less about filling a role and more about helping a company make one of the biggest business decisions it will make that year.

This guide breaks down how to make that decision well, what executive recruitment covers, and why it starts with strategy, not a spec.

Life sciences executive recruitment covers senior leadership hires, generally VP level and above. That includes SVPs, C-suite roles, General Managers, and regional heads: the people who set direction for the organization.

The title on the contract counts for less than the scope of the person’s influence. A VP who owns a product launch across three markets carries more weight than a grander title attached to a narrow remit. The honest way to define an executive hire is by impact, not by hierarchy.

Executive recruitment in the life sciences isn’t just senior specialist hiring.

A senior specialist is hired for what they know. An executive is hired for what they can build.

A specialist earns their seat through depth: a regulatory expert who knows a submission pathway cold, or a scientist who has run the assay a hundred times.

An executive is judged on something harder to measure. Can they set a vision people believe in? Can they carry a team through change? Can they make a hard call with half the information and own the result?

Those questions, not a longer list of technical boxes, decide who belongs at this level.

As a recruiter, the first conversation I have with clients is rarely about the role. It is about the company.

Where is the business today? Where does it want to be in three years? And why does this hire exist at all? A replacement for someone who left is a different brief from a first commercial leader before a launch, which is different again from a VP brought in to steady a function that has drifted.

Only once those answers are on the table can you define the kind of leader who fits.

When you start with the job description, you tend to describe the person who just left. But start with the business, and you describe the person the company needs next.

At the executive level, the people who fit these roles aren’t scanning job boards. They are already succeeding somewhere else, which means that the search depends on knowing precisely who you are looking for and why they would consider a move.

The life sciences industry is technical, tightly regulated, and built on small, closely connected talent pools. In a competitive industry like that, a few things set executive hiring apart even further:

• Scientific and regulatory credibility that a generalist recruiter can’t assess from a CV alone
• Candidate pools so specialised that, inside a given therapeutic area, most senior leaders already know one another
• Confidentiality when you are replacing a sitting executive or building ahead of a funding round
• Work permits and language, which shape who can realistically take a Swiss or Europe-based role.

Because of this, a strong shortlist depends less on volume and more on knowing the market well enough to reach the few people who fit and start a credible conversation with them.

Learn more about life science recruitment.

A few years ago, most senior hiring focused on growth. Companies were scaling fast and wanted leaders who could scale with them. That has shifted. The priority now is people who can build something durable and hold a team steady through periods of uncertainty.

Technical expertise still counts, especially in an industry as specialised as the life sciences sector. But everyone at VP or C-level arrives with a strong CV, so the deciding factor has moved to how someone leads. Namely, to how they make decisions and handle change.

Candidates have changed, too.

Senior leaders now ask sharper questions about culture, how decisions get made, and whether the company knows where it is going.

Then there is AI, which has made parts of the process faster, sharpening research and market mapping and clearing away administrative work.

AI makes research and market mapping faster, but it doesn’t replace the understanding of why someone would leave a strong role for another company. That part stays uniquely human.

When a leader leaves, the instinct is to find someone who looks like them with the same background and CV. Sometimes that is right, but, in my experience, it’s often a mistake.

The company doing the hiring is rarely the company that hired the last person. The strategy has moved on, the market has moved on, and the role that made sense three years ago is likely not the role the business needs now.

A good executive search should challenge your assumptions, not simply confirm them.

So the more useful question isn’t “who can replace this person?” It is “what does the business need next, and who can deliver it?” That reframe changes the brief, the shortlist, and often the outcome.

The toughest briefs sit where deep technical demand meets a shallow talent pool.

Right now, that includes:

• Cell and gene therapy leadership
• Regulatory CMC
• Technical operations
• Commercial leaders

The difficulty is rarely the technical background on its own.

It’s finding someone who has the science, has led teams and delivered results, and wants to make a move. Each condition narrows the field, and together they narrow it to a handful of names.

This is why these searches reward a recruiter who already knows the market like headcount AG.

A strong executive search starts with the business, not the brief. You want to understand the strategy, the gap, and the kind of leader who fits.

From there it moves into research and market mapping, building a picture of who is out there and how competitors are structured. Then come confidential approaches to people who are not looking, careful assessment against the leadership team as well as the role, and a practical shortlist.

The final stretch, offer and onboarding, is where a search is won or lost.

In my experience, most searches take three to four months. When they run long, the delay rarely comes from candidates.

The best candidates don’t stay on the market. Companies that move decisively have the biggest advantage.

More often, a search stalls when the brief keeps shifting, too many stakeholders join late, or decisions take too long.

Not every senior hire needs the same approach:

• Retained search suits critical, confidential, or hard-to-fill roles, where a partner commits to the mandate and works it through to completion
• Contingency recruitment can work for less senior or more open roles, where speed and reach across active candidates are important
• An in-house talent team handles volume well and knows the culture intimately, but it often has less reach into the passive senior leaders who aren’t applying anywhere

For most VP and C-suite briefs in life sciences, retained search is the best option, because the roles are confidential, the pool is small, and the cost of the wrong hire is high.

The best executive searches give you a lot more than a name on an offer letter.

By the end of a well-run process, you should understand your market far better than when you started: who the strong leaders are, how competitors have built their teams, what compensation looks like at this level, and what kind of leadership your next phase will call for.

If all you have at the end of an executive search is a shortlist, you have missed part of the value.

Market intelligence feeds decisions well beyond the single hire. It shapes succession planning, team design, and how you position yourself as an employer against the companies chasing the same people.

A good recruitment partner leaves you sharper about the market, not simply staffed.

Whether you are hiring the leader who will shape your next phase or preparing for your own move into one of these roles, specialist support changes the odds.

Since 2012, headcount AG has placed VP and C-suite talent across pharma, biotech, medtech, and digital health in Switzerland and the DACH region. Science is in our DNA, and we know this competitive market intimately.

Looking to hire leadership talent? Hire with us. Ready for your next role? Explore life science jobs.